Healthcare DIVE July 24, 2024
Susanna Vogel and Rebecca Pifer

Top executives of CVS Caremark, Optum Rx and Express Scripts made a rare congressional appearance to defend pharmacy benefit managers’ drug pricing policies.

In a House Committee on Oversight and Accountability hearing Tuesday, representatives from across the aisle pressed executives from the largest pharmacy benefit managers in the nation — CVS Caremark, UnitedHealth Group’s Optum Rx and Cigna’s Express Scripts — on their role in rising prescription drug costs.

While congressional hearings on PBMs have ticked up in frequency, it is rare for lawmakers to hear directly from top decision-makers at the companies. The last time was in 2019, when a different group of executives appeared before the Senate Finance Committee.

That changed yesterday when Adam Kautzner, president of Express...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
First Comprehensive Review of SMA Drugs Offers Long-Term Insights, Outcome Gaps
Drugmaker might be 1st healthcare company to top $1 trillion valuation
Prescription drug spending grew even after rebates
Remote monitoring and pharmacist helps improve hard-to-control blood pressure, research shows
Pharma Pulse 9/5/24: Legal Advice for DSCSA Compliance Teams, Pharmacy Students Discuss Learning Through Social Media Platforms & more

Share This Article